Skip to main content
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2001 Apr;84(4):337–339. doi: 10.1136/adc.84.4.337

A novel scheme for the reporting of adverse drug reactions

A Clarkson 1, E Ingleby 1, I Choonara 1, P Bryan 1, P Arlett 1
PMCID: PMC1718721  PMID: 11259235

Abstract

BACKGROUND—The safety of medicines used in children is of considerable public interest, yet available data to monitor the safety of medicines in children is limited.
AIMS—To raise awareness and stimulate reporting of adverse drug reactions (ADRs) in children in the Trent region.
METHODS—A pilot Paediatric Regional Monitoring Centre (PRMC) has been established in the Trent region. The scheme operates as an extension of the UK's spontaneous reporting scheme, the Yellow Card Scheme run by the Medicines Control Agency and the Committee on Safety of Medicines. Proactive interventions including a monthly reminder letter and presentations to staff in the identified hospitals have been made.
RESULTS—During the first year of the PRMC, 95 reports were received from the Trent region compared to 40 for the previous year. Twenty four of these reports were for medicines used "off label". The 95 reports involved 105 drugs and 171 suspected ADRs. Twenty six of the ADRs (15%) were considered medically significant.
CONCLUSIONS—The number of ADR reports from the Trent region has increased considerably in the first year of the scheme. The results show that intensive education and promotion of ADR reporting can result in a major increase in reporting. This initiative will increase our knowledge about the safety of medicines used to treat children and so help protect public health.



Full Text

The Full Text of this article is available as a PDF (81.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bonati M., Marchetti F., Zullini M. T., Pistotti V., Tognoni G. Adverse drug reactions in neonatal intensive care units. Adverse Drug React Acute Poisoning Rev. 1990 Summer;9(2):103–118. [PubMed] [Google Scholar]
  2. Choonara I. A. Anticonvulsant toxicity in paediatric out-patients. Br J Clin Pract. 1988 Jan;42(1):21–23. [PubMed] [Google Scholar]
  3. Choonara I., Gill A., Nunn A. Drug toxicity and surveillance in children. Br J Clin Pharmacol. 1996 Oct;42(4):407–410. doi: 10.1046/j.1365-2125.1996.04563.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Conroy S., Choonara I., Impicciatore P., Mohn A., Arnell H., Rane A., Knoeppel C., Seyberth H., Pandolfini C., Raffaelli M. P. Survey of unlicensed and off label drug use in paediatric wards in European countries. European Network for Drug Investigation in Children. BMJ. 2000 Jan 8;320(7227):79–82. doi: 10.1136/bmj.320.7227.79. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Morrison-Griffiths S., Pirmohamed M. Specialist nurse reporting of adverse drug reactions. Prof Nurse. 2000 Feb;15(5):300–304. [PubMed] [Google Scholar]
  6. Turner S., Longworth A., Nunn A. J., Choonara I. Unlicensed and off label drug use in paediatric wards: prospective study. BMJ. 1998 Jan 31;316(7128):343–345. doi: 10.1136/bmj.316.7128.343. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES